Viewing Study NCT02497820


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2026-03-03 @ 6:44 PM
Study NCT ID: NCT02497820
Status: NOT_YET_RECRUITING
Last Update Posted: 2016-08-25
First Post: 2015-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers
Sponsor: Tel-Aviv Sourasky Medical Center
Organization:

Organization Data

Organization:
Class: OTHER_GOV
Study ID: 0246-14-TLV
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER_GOV View